Acute coliform mastitis in lactating dairy cows is occasionally fatal. Endotoxemia \[[@r9]\], metabolic acidosis \[[@r2]\], uremia \[[@r1], [@r9]\] and increased aspartate aminotransferase (AST) activity \[[@r2], [@r13]\] are commonly observed in these cows. Bacteremia has been reported to occur in 32% \[[@r2], [@r14]\] to 75% \[[@r9]\] of cows with clinical coliform mastitis. Endotoxemia and disseminated intravascular coagulation in cows with acute *Escherichia coli* mastitis are the generally recognized causes of fatality \[[@r9]\].

To our knowledge, there are few reports on prediction of fatal acute *E. coli* mastitis \[[@r7], [@r15]\]. Significantly decreased milk production and high bacterial growth in the infected quarters are reported to predict fatal outcomes following experimental *E. coli* mammary infection \[[@r7]\]. Severe systemic signs include elevated rectal temperature, degree of enophthalmos, rumen contraction rate and signs of depression, which are reported to predict 48% of fatal outcomes resulting from clinical cases of coliform mastitis \[[@r15]\].

In our previous study, dysstasia associated with decreased antithrombin activity and platelet counts along with increased hematocrit (HCT) and blood non-esterified fatty acid (NEFA) concentrations were confirmed as prognostic parameters associated with a high mortality after therapeutic treatment of dairy cows with acute *E. coli* mastitis \[[@r6]\]. The ability of these five parameters to predict fatal outcomes following acute *E. coli* mastitis in dairy cows remains to be validated.

The aim of this study was to evaluate the predictors of fatal outcomes resulting from acute *E. coli* mastitis. In our present study, receiver operator characteristic (ROC) curve analysis was performed to identify potential cut-off values for the five parameters: dysstasia, antithrombin activity, platelet counts, HCT and NEFA.

Predictors of fatal outcomes resulting from acute *E. coli* mastitis were determined by ROC curve analysis of 24 Holstein dairy cows, which were fed in 17 dairy farms of Hokkaido, Japan. All 24 cows had an *E. coli* infection that was confirmed by the identification of the causative pathogen from infected quarter milk samples and one or more of the following findings on day 1: rectal temperature \>40°C, heart rate \>120 beats/min, respiratory frequency \>30 breaths/min and blood total leukocyte counts \<5,000/*µl*.

The cut-off values for differentiating between non-survivors and survivors amongst the 24 clinical cases were determined using data on dysstasia, HCT values, NEFA concentration, antithrombin activity and platelet counts. The sensitivity (proportion of non-survivors that were predicted to have a fatal outcome), specificity (proportion of survivors that were predicted to survive), predictive value (proportion of cows predicted to have a fatal outcome that were indeed non-survivors) and likelihood ratio (sensitivity/\[1-specificity\]) for non-survivors were determined for several ranges of the blood test parameters and dysstasia. ROC curves \[sensitivity vs (1-specificity)\] were constructed to identify the optimum threshold among the significant cut-off values. Odds ratios and 95% confidence intervals were determined to establish significant differences. A *P*-value of \<0.05 was considered statistically significant.

The utility of the predictors was verified through their use in a trial on day 2 involving 34 clinical cases that were sampled similarly from 32 dairy farms in Hokkaido, Japan. The 34 cows had *E. coli* infection that had been confirmed by isolation of bacteria from infected quarter milk samples and one or more of the following findings on day 1: rectal temperature \>40°C, heart rate \>120 beats/min and respiratory frequency \>30 breaths/min. All of the tested bacterial isolates were sensitive *in vitro* to kanamycin as measured by antimicrobial susceptibility test using the disk diffusion method.

As the systemic antimicrobial therapy, kanamycin sulfate was administered to cows with acute *E. coli* mastitis on days 1, 2 and 3 after the onset. All cows were administered kanamycin sulfate (4,000--6,000 mg/cow/day) intramuscularly, 7.2% sodium chloride solution (2,000 m*l*/cow/day) intravenously, and a combination of kanamycin sulfate (300 mg/cow/day) and penicillin-G-procaine (300,000 U/cow/day) as an intra-mammary infusion. Additionally, 1,000 U of heparin sodium (25--50 m*l*/cow/day), physiological saline solution (2,000--8,000 m*l*/cow/day) and 5% glucose (2,000--5,000 m*l*/cow/day) were intravenously administered when they were judged to be necessary. The frequency and dosages of medical treatments were identical for both survivors and non-survivors. On day 1, quarter milk \[[@r8]\] from affected cows was collected aseptically into sterilized culture tubes. *E. coli* isolates were identified using a specific biochemical system (Sysmex-bioMerieux Co., Ltd., Tokyo, Japan) and a laboratory-designed kit (VITEK 2; Sysmex-bioMerieux Co., Ltd.) in a diagnostic laboratory (Kishimoto Medical Lab., Tomakomai, Japan). On day 2, 8--10 m*l* of peripheral blood was collected from the jugular vein into evacuated tubes (BD Vacutainer SST II K2 EDTA; Becton, Dickinson and Co., Tokyo, Japan) and into tubes containing 3.8% sodium citrate as an anticoagulant (NP-CS0457; Nipro, Tokyo, Japan). Analyses of the four serum parameters were conducted in a diagnostic laboratory (Kishimoto Medical Lab.) only on day 2 and not on day 1 or 3. Antithrombin activity was measured by a chromogenic assay (N-Assay L AT III; Nittobo, Tokyo, Japan) with an automated instrument (JCA-BM12; JEOL, Tokyo, Japan) using plasma treated with sodium citrate. Serum NEFA concentration was measured using an autoanalyzer (JCA-BM2250; JEOL). HCT, platelet counts and white blood cell counts were measured with an automated instrument (Analyzer SE-9000; Sysmex) using plasma treated with EDTA.

There were 26 surviving cows (survivors) from among the 34 affected cows, with 8 cows euthanized (non-survivors) after unsuccessful therapeutic treatment. The cows were euthanized on days 4 (2 cows), 5 (3 cows), 6 (1 cow), 7 (1 cow) and 8 (1 cow). Among the 26 surviving cows, clinical symptoms resolved on days 3 (8 cows), 4 (7 cows), 5 (5 cows), 6 (2 cows), 7 (3 cows) and 9 (1 cow).

The sensitivity, specificity, predictive value and likelihood ratio for non-survivors were also determined for the 34 clinical cases. Odds ratio and 95% confidence interval around the odds ratio were determined to establish significant differences.

Cows with acute *E. coli* mastitis that met the prognostic criteria on day 2, comprising HCT \>32%, NEFA \>0.4 mEq/*l*, antithrombin activity \<120%, platelet counts \<15 × 10^4^/m*l* and presence of dysstasia, were at higher risk of dying or being euthanized. If at least three of these parameters were met, a fatal outcome was predicted. From among the 24 clinical cases, cows with three or more parameters that exceeded the cut-off values were at a significantly (*P*\<0.01) higher risk of death or euthanasia ([Table 1](#tbl_001){ref-type="table"}Table 1.Associations of hematocrit, non-esterified fatty acid, antithrombin activity, platelet count and dysstasia with the fatal outcome of naturally occurring acute *Escherichia coli* mastitis in 24 clinical casesParametersCutpointOdds ratio^a)^95% CI^a)^*P*^a)^Sensitivity\
(%)Specificity\
(%)Predictive\
value (%)Likelihood\
ratioMeasured at onset (Day 1, n=24)Hematocrit (%)\>323.30.5 to 22.90.2450.076.542.92.1Non-esterified fatty acid (mEq/*l*)\>0.44.80.7 to 35.20.1366.770.644.42.3Antithrombin activity (%)\<120--^b)^--^b)^0.2914.3100.0100.0--^b)^Platelet count (×10^4^/m*l*)\<150.80.1 to 5.00.6042.952.927.30.9Dysstasiapositive--^b)^--^b)^\<0.0171.4100.0100.0--^b)^At least 3 parameters fell within the ranges12.01.0 to 148.30.0642.994.175.07.29Measured in one day after onset (Day 2, n=24)Hematocrit (%)\>32--^b)^--^b)^\<0.0171.4100.0100.0--^b)^Non-esterified fatty acid (mEq/*l*)\>0.4--^c)^--^c)^\<0.01100.062.553.82.7Antithrombin activity (%)\<12010.01.2 to 81.80.0457.188.266.74.9Platelet count (×10^4^/m*l*)\<153.60.5 to 24.00.1971.458.841.71.7Dysstasiapositive--^b)^--^b)^\<0.01100.0100.0100.0--^b)^At least 3 parameters fell within the ranges--^b)^--^b)^\<0.01100.094.187.517Measured in two day after onset (Day 3, n=18)Hematocrit (%)\>32--^c)^--^c)^\<0.01100.091.785.712.0Non-esterified fatty acid (mEq/*l*)\>0.4--^c)^--^c)^0.03100.058.354.52.4Antithrombin activity (%)\<120--^c)^--^c)^\<0.01100.075.066.74.0Platelet count (×10^4^/m*l*)\<157.00.6 to 79.90.1283.358.350.02.0Dysstasiapositive--^b)^--^b)^\<0.0183.3100.0100.0--^b)^At least 3 parameters fell within the ranges--^b)^--^b)^\<0.01100.083.375.06a) From Fisher's exact probability test. 95% CI=95% confidence interval around the odds ratio. b) Odds ratio, 95% CI and likelihood were not calculated, because none of surviving cows was less than the cutpoint. c) Odds ratio and 95% CI were not calculated, because all of these values of non-surviving cows were included a range designated by each cutpoint.). The fatal outcomes of the affected cows were predicted on day 2 (*P*\<0.01) and day 3 (*P*\<0.01), but not on day 1 (*P*=0.06). The sensitivity, specificity, predictive value and likelihood ratio of the prognostic criteria on days 2 and 3 were 100%, 94.1%, 87.5% and 17, and 100%, 83.3%, 75.0% and 6, respectively ([Table 1](#tbl_001){ref-type="table"}).

When these criteria and cut-off values were applied to 34 other clinical cases, cows with three or more of the parameters that met the criteria on day 2 were seven times more likely to die compared with cows with fewer than three of the parameters that met the criteria on day 2 (*P*\<0.05, [Table 2](#tbl_002){ref-type="table"}Table 2.Associations of hematocrit, non-esterified fatty acid, antithrombin activity, platelet count and dysstasia with the fatal outcome of naturally occurring acute *Escherichia coli* mastitis in 34 clinical casesParametersCutpointOdds ratio^a)^95% CI^a)^*P*^a)^Sensitivity\
(%)Specificity\
(%)Predictive\
value (%)Likelihood\
ratioObserved at onset (Day 1, n=34)Dysstasiapositive1.80.3 to 12.50.4425.084.633.31.6Observed in one day after onset (Day 2, n=34)Hematocrit (%)\>324.50.8 to 24.10.0862.573.141.72.3Non-esterified fatty acid (mEq/*l*)\>0.43.20.6 to 16.30.1662.565.435.71.8Antithrombin activity (%)\<1202.30.4 to 11.60.2862.557.731.31.5Platelet count (×10^4^/m*l*)\<1512.61.9 to 82.1\<0.0175.080.854.53.9Dysstasiapositive12.82.0 to 82.9\<0.0162.588.562.55.4At least 3 parameters fell within the ranges7.01.2 to 39.6\<0.0562.580.850.53.3Observed in two day after onset (Day 3, n=24)Dysstasiapositive21.02.4 to 185.9\<0.0175.087.533.36.0a) From Fisher's exact probability test. 95% CI=95% confidence interval around the odds ratio.). The sensitivity, specificity, predictive value and likelihood ratio of the prognostic criteria for the cows on day 2 were 62.5%, 80.8%, 50.5% and 3.3, respectively ([Table 2](#tbl_002){ref-type="table"}).

When the predictive value of each of these five parameters was considered as an individual prognostic criterion, dysstasia was the most reliable parameter for diagnosing fatal outcomes resulting from acute *E. coli* mastitis. Except for day 1, among these 34 cows, those with dysstasia were at a significantly higher risk of dying or being euthanized (*P*\<0.01) ([Tables 1](#tbl_001){ref-type="table"} and[2](#tbl_002){ref-type="table"}).

The fatal outcomes resulting from acute *E. coli* mastitis could be predicted on day 2 after onset. Cows showing severe clinical signs for three consecutive days after onset of naturally occurring acute *E. coli* mastitis were found to be at a significantly higher risk of dying or being culled \[[@r11]\]. Cows showing severe systemic signs for four consecutive days after experimentally induced *E. coli* mammary infections were euthanized \[[@r7]\], whereas cows with no signs on day 2 after infection recovered \[[@r7], [@r10]\]. Significantly increased HCT and NEFA concentrations, and significantly decreased antithrombin activity and platelet counts were observed in non-survivors, compared with survivors on day 2 and day 3, but not on day 1 \[[@r6]\]. The differences in clinical symptoms between non-survivors and survivors became apparent starting from day 2 after the onset of acute *E. coli* mastitis.

Increased HCT and NEFA concentrations were associated with a higher risk of a fatal outcome from acute *E. coli* mastitis. Non-surviving cows showed higher HCT (39%) than that of surviving cows (35%) in clinical acute coliform mastitis \[[@r2]\]. Severe symptoms were observed in cows with higher NEFA (0.49 mEq/*l*) prior to experimental intramammary *E. coli* infection, compared with cows with lower NEFA (0.31 mEq/*l*) \[[@r12]\].

Decreased antithrombin activity and platelet counts \[[@r4]\] have been observed in patients with lethal disseminated intravascular coagulation. In human patients exhibiting decreased (\<50%) antithrombin activity, a 96% mortality rate has been observed \[[@r5]\]. Platelet count was also an accurate indicator of mortality in human sepsis; significantly decreased platelet count (17.4 × 10^4^/m*l*) has been observed in non-survivors compared with survivors (26.8 × 10^4^/m*l*). \[[@r3]\]

Dysstasia may be a major parameter for predicting fatal outcomes resulting from acute *E. coli* mastitis. Recumbency at 2 days after experimental *E. coli* mammary infection was reported as a common clinical finding in two cows that were euthanized because of severe clinical mastitis \[[@r7]\]. Of the 56 cows, a diagnosis of dysstasia at the first clinical examination was made in 12 with toxic clinical mastitis, with 31 eventually slaughtered or euthanized \[[@r1]\]. Dysstasia was the most reliable predictor of a fatal outcome in this study ([Tables 1](#tbl_001){ref-type="table"} and[2](#tbl_002){ref-type="table"}). Examinations focused on dysstasia may help to predict fatal outcomes resulting from acute *E. coli* mastitis.

This study verified that fatal outcomes for dairy cows with acute *E. coli* mastitis can be accurately predicted using specific prognostic criteria and cut-off values of HCT \>32%, NEFA \>0.4 mEq/*l*, antithrombin activity \<120% and platelet counts \<15 × 10^4^/m*l*, along with the presence of dysstasia. The usefulness of these prognostic criteria and cut-off values was verified in cows with fatal *E. coli* mastitis on dairy farms.
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